Yahoo! Stings, VMWare Swings, eBay Dings, Glaxo Rings

Recs

3

It's hard to live up to the hype.

The pressure was on Yahoo! (Nasdaq: YHOO) to step up to the plate and swing for the fences in the most important quarterly at-bat of its corporate life ... and the company laid down a bunt single.

Revenue inched just 9% higher -- or 14% higher excluding traffic acquisition costs -- but adjusted profitability and free cash flow fell slightly over last year's first-quarter showing. In the end, this doesn't appear to be a company that either needs Microsoft (Nasdaq: MSFT) or is justified in refusing its advances. It may have narrowly topped Wall Street's hosed-down expectations, but its current-quarter guidance calls for meager top-line gains of 2% to 14% with yet another year-over-year decline in operating income.

In the end, last night's report and subsequent conference call aren't enough to push this deal to any kind of resolution.

That is the worst kind of stalemate, especially when both halves of the Microhoo equation are wearing their egos on their sleeves.

Yahoo! actually posted declines in both its international and affiliate network revenue, two key areas where the company was supposed to fill gaping holes in Microsoft's online strategy. That may lead Microsoft to reconsider whether Yahoo! is its best match, but Yahoo! may be doing a little thinking on its own, since it put up healthy advances in its domestic display-advertising stronghold.

If you've tired of the Microhoo moniker, join the club. This was supposed to be the earnings report that settled things once and for all. A bad quarter and Yahoo! would have fallen into Microsoft's outstretched arms. A good quarter and Yahoo! would have had every right to tell Microsoft to move along. Instead, we take another swan dive into mediocrity's slow-drying cement.

Get a room, Microhoo? Sure, but it's starting to look more like another waiting room instead.

News to go
If you wanted to see fence-swinging, your best bet was VMware (NYSE: VMW). The virtualization software leader posted a 69% spike in quarterly revenue. Earnings growth wasn't as kind, but top-line growth is what you really like to see in an early-stage growth stock like VMware as an indicator of its virtualization solutions sticking to corporations. The company is looking to grow its top line at a 50% clip for all of 2008, so expect the good times to continue.

Evoking the wrath of a minority investor scorned, Craigslist is being sued by eBay (Nasdaq: EBAY) over the recent dilution of the 28.4% stake that eBay acquired four years ago. Why would eBay go after something so petty when it has more pressing matters to contend with, like getting its namesake auction website back on track or justifying the lofty price tag it paid for Skype? I guess we'll have to see legal developments unfold to get the answers we crave. Is there a "settle it now" button available, to end this quickly and amicably?

If you're not into the Microhoo brand, maybe Glaxtris will win you over. GlaxoSmithKline (NYSE: GSK) is buying Sirtris Pharmaceuticals (Nasdaq: SIRT) in an all-cash deal. The $22.50-a-share price is a healthy 84% premium to where Sirtris closed yesterday. The deal will give Glaxo a foothold in the promising biotech realm of sirtuins, an enzyme class that is showing promise in the aging process of certain diseases. Kudos to Sirtris for keeping the deal quiet, since its stock actually fell sharply yesterday ahead of the announcement. You can pity those who sold, or you can cross your fingers and hope that an already long corporate name doesn't grow even longer as SirGlaxoSmithKline.

Hoping to put the royalty back into its kinghood, reports out of England find Burger King (NYSE: BKC) gearing up to launch a $170 burger in select locations of the United Kingdom. Made with Kobe beef and topped with ritzy add-ons like foie gras and a rare bleu cheese, it's clearly more a headline-snagging novelty than a pricing strategy shift. Let's hope so, anyway. What's next? Replacing the paper crowns they give away with actual jewel-encrusted ones?

Sen. Hillary Clinton won the Pennsylvania Democratic primary last night. If you're looking for coverage on the pivotal vote, complete with exit polls, colorful commentary, and intricate maps of red and blue states, you have most definitely clicked on the wrong website this morning.

Have a great day out there.

Closed for 15 months – opening 10 days only! Get notified ahead of time as our expert portfolio manager invests $1 MILLION in the best opportunities from across The Motley Fool’s premium investment services. This is the first open since August 2008, by invitation only. Enter email below.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 627602, ~/Articles/ArticleHandler.aspx, 11/10/2009 7:00:27 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

The Must-Read Story on Fool.com
Health-Care Reform: A Tale of Two Chambers

Related Tickers

11/9/2009 4:02 PM
BKC $17.50 Down -0.05 -0.28%
Burger King Holdin… CAPS Rating: **
GSK $41.37 Up +0.85 +2.10%
GlaxoSmithKline pl… CAPS Rating: *****
VMW $41.06 Up +0.99 +2.47%
VMware CAPS Rating: ****
EBAY $23.27 Down -0.07 -0.30%
eBay, Inc. CAPS Rating: ***
MSFT $28.99 Up +0.47 +1.65%
Microsoft Corp CAPS Rating: ***
YHOO $16.02 Up +0.08 +0.50%
Yahoo!, Inc. CAPS Rating: **

Community: Investing Wiki

Term Of The Hour

Biotechnology: Biotechnology uses biological processes to solve problems in such areas as health and medicine, agriculture and manufacturing.

Want to learn more or edit this definition?
Click here to read more!